<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths</h2>
    <div class="badge">2025-09-15T12:56:00+00:00</div>
    <ul>
      <li>Pfizer and Novavax slipped nearly 4%.</li>
<li>Moderna and BioNTech fell more than 7% each after the WP article’s release.</li>
<li>18-19, 2025 (Thursday and Friday) to discuss the safety, effectiveness and clinical necessity of vaccines.</li>
<li>This announcement came just a couple of weeks after the FDA approved updated COVID-19 vaccines for the 2025-26 vaccination season.</li>
<li>Under the new policy, all vaccines are cleared for adults aged 65 and older.</li>
<li>Future of COVID-19 Vaccine-Makers in Jeopardy Shares of COVID-19 vaccine-makers declined following the news.</li>
<li>Investors were concerned that renewed regulatory attention could further dampen the already slowing COVID-19 vaccine demand.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths\n• Pfizer and Novavax slipped nearly 4%.\n• Moderna and BioNTech fell more than 7% each after the WP article’s release.\n• 18-19, 2025 (Thursday and Friday) to discuss the safety, effectiveness and clinical necessity of vaccines.\n• This announcement came just a couple of weeks after the FDA approved updated COVID-19 vaccines for the 2025-26 vaccination season.\n• Under the new policy, all vaccines are cleared for adults aged 65 and older.\n• Future of COVID-19 Vaccine-Makers in Jeopardy Shares of COVID-19 vaccine-makers declined following the news.\n• Investors were concerned that renewed regulatory attention could further dampen the already slowing COVID-19 vaccine demand." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/covid-19-vaccine-stocks-fall-125600031.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>